Impact of Chronic Air Pollution on Non-cystic Fibrosis Bronchiectasis

We aim at investigation the impact of chronic air pollution exposure on non-cystic fibrosis bronchiectasis outcome.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bronchiectasis Bronchial Diseases Respiratory Tract Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

UZ Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

About this study

Patient files will be search for time of death and cause of death.
Other variables will be collected: bacterial culture results, therapy, gender, age, etc.
These data will be linked with pollution data: trafic load, distance to major road, etc.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

HRCT diagnosis of bronchiectasis
recurrent infections or chronic sputum production
patients between 18 and 65 years old.

Exclusion criteria

Cystic Fibrosis
Tumoral disease
Traction bronchiectasis due to interstitial lung disease
patients older than 65 years or younger than 18 years at recruitment
COPD

Treatment and study plan

Primary outcomes

Death

Time frame: 6 years

From June 2006 till October 2012, enrolled patients' medical file will be screened if death has occurred. If so, cause of death will be search for in the patients' file.

Sponsors and collaborators

Lead sponsor

Universitaire Ziekenhuizen KU Leuven

Other

Registry information

Important dates

Study start: 2006
Primary completion: 2012
Study completion: 2013
First posted: Jul 23, 2013
Registry last updated: Jul 23, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed